Drug Type Prophylactic vaccine |
Synonyms- |
Target- |
Action stimulants |
Mechanism Immunostimulants |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingPhase 1/2 |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Influenza, Human | Phase 2 | United States | 17 May 2023 |
Phase 1/2 | 170 | Influenza A G1 mHA (Group 1: Influenza A G1 mHA 45 mcg (Two Doses)) | saoqkpjdsg = qdzdgqejfz brmrgvfeet (bojhytimgf, beycqptljh - sdcauczjgw) View more | - | 08 Sep 2025 | ||
(Group 2: Influenza A G1 mHA 45 mcg With Al(OH)3 (Two Doses)) | saoqkpjdsg = brwubudhzk brmrgvfeet (bojhytimgf, sfyzbhvtub - mstzbxsbuj) View more |





